Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Malaria Journal
Published in: Malaria Journal 1/2016

Open Access 01-12-2016 | Erratum

Erratum to: Natural products from Zanthoxylum heitzii with potent activity against the malaria parasite

Authors: Christopher Dean Goodman, Ingvild Austarheim, Vanessa Mollard, Bertin Mikolo, Karl Egil Malterud, Geoffrey I. McFadden, Helle Wangensteen

Published in: Malaria Journal | Issue 1/2016

Login to get access

Excerpt

After publication of the original article [1], it came to the authors’ attention that an error in the abstract was introduced during production of the article. In the Results section of the abstract, ‘pellitorine’ appears incorrectly as ‘pellitories’. The original article has been updated to correct the misspelling. …
Literature
1.
Metadata
Title
Erratum to: Natural products from Zanthoxylum heitzii with potent activity against the malaria parasite
Authors
Christopher Dean Goodman
Ingvild Austarheim
Vanessa Mollard
Bertin Mikolo
Karl Egil Malterud
Geoffrey I. McFadden
Helle Wangensteen
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2016
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-016-1608-8

Other articles of this Issue 1/2016

Malaria Journal 1/2016 Go to the issue

Research

The role of gender on malaria preventive behaviour among rural households in Kenya

Research

A yeast strain associated to Anopheles mosquitoes produces a toxin able to kill malaria parasites

Research

Oral artemisinin monotherapy removal from the private sector in Eastern Myanmar between 2012 and 2014

Research

The return of chloroquine-susceptible Plasmodium falciparum malaria in Zambia

Research

Performance and user acceptance of the Bhutan febrile and malaria information system: report from a pilot study

Research

Development and evaluation of a spatial decision support system for malaria elimination in Bhutan
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits